March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
The Impact Of Corneal Haze On Visual Outcomes After Descemet’S Stripping With Automated Endothelial Keratoplasty (dsaek)
Author Affiliations & Notes
  • Brooke E. Miller
    Flaum Eye Institute, University of Rochester Medical Center, Rochester, New York
  • Christine Callan
    Flaum Eye Institute, University of Rochester Medical Center, Rochester, New York
  • Steven Ching
    Flaum Eye Institute, University of Rochester Medical Center, Rochester, New York
  • Krystel Huxlin
    Flaum Eye Institute, University of Rochester Medical Center, Rochester, New York
  • Holly B. Hindman
    Flaum Eye Institute, University of Rochester Medical Center, Rochester, New York
  • Footnotes
    Commercial Relationships  Brooke E. Miller, None; Christine Callan, None; Steven Ching, None; Krystel Huxlin, Bausch and Lomb (F); Holly B. Hindman, None
  • Footnotes
    Support  K23EY019353, K23EY019353-01S1
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 45. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Brooke E. Miller, Christine Callan, Steven Ching, Krystel Huxlin, Holly B. Hindman; The Impact Of Corneal Haze On Visual Outcomes After Descemet’S Stripping With Automated Endothelial Keratoplasty (dsaek). Invest. Ophthalmol. Vis. Sci. 2012;53(14):45.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To investigate the effect of corneal haze, measured as intensity profiles using Optical Coherence Tomography (OCT), on clinical visual outcomes after DSAEK over time.

Methods: : This is a prospective human study in which 20 eyes of 20 patients with either Fuchs’ endothelial dystrophy or pseudophakic bullous keratopathy underwent DSAEK surgery. All subjects received an ophthalmic examination pre-operatively and at 1, 3, 6, and 12 months post-DSAEK. OCT was used to quantify haze at the graft-host interface by measuring pixel intensity across the interface. At each timepoint, monocular best spectacle corrected visual acuity (BSCVA) and glare-disability (using brightness acuity testing (BAT) with BSCVA in place) were recorded. When comparing a single measure across time, Kruskal-Wallis (K-W) tests with Dunn’s multiple comparisons post-tests and Bonferroni adjustments were performed. Spearman Rank tests were conducted to determine correlations.

Results: : Significantly different interface intensities, BSCVA, and BAT results were identified across timepoints (p<0.0002, p<0.0001, p<0.005, respectively). Dunn’s post hoc tests indicated significantly less intensity, improved logMAR BSCVA, and improved BAT performance at 12 months [1.46 +/- 0.12, (mean +/- SD), 0.22+/- 0.14, Snellen 20/33, and 0.33 +/- 0.18, Snellen 20/43, respectively] as compared to 1 month (1.80 +/- 0.27, 0.47 +/- 0.21, Snellen 20/60, and 0.50+/- 0.29, Snellen 20/63) (D=26.3, p< 0.001 for intensity and D=36.5, p<0.001 for BSCVA, and D=-25.5, p<0.01 for BAT). Significant negative correlations were found between mean interface pixel intensity and BSCVA (Spearman r = -0.3363, 95% CI -0.54 to -0.10, p = 0.005) and mean interface pixel intensity and BAT testing (Spearman r = -0.1989, 95% CI -0.33 to -0.06, p = 0.005).

Conclusions: : Between 1 and 12 months post-DSAEK, mean interface intensity significantly decreases, while BSCVA and BAT significantly improve. Both BSCVA and BAT testing were negatively correlated with mean interface intensity. These data suggest that light scatter plays a significant role in limiting visual performance in post-DSAEK patients. Further research focused on elucidating the cause of interface-induced light scatter is indicated.

Keywords: cornea: endothelium • transplantation • visual acuity 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×